Don't miss our presentations at this year's Congress!
- Seerlinq: non invasive fluid status monitoring in heart failure
Speaker: Branislav Bezak, Premedix Academy; Date: 24 March 2023; Time: 14:30 - 14:50
- Machine learning score to predict cardiogenic shock in patients with myocardial infarction (#STOPSHOCK)
Speaker: Allan Bohm, Premedix Academy; Date: 24 March 2023; Time: 14:50 - 15:10
- A.I. - based prediction of cardiogenic shock
Speaker: Allan Bohm, Premedix Academy; Date: 25 March 2023; Time: 08:45 - 09:00
- Vasodilators in cardiogenic shock
Speaker: Allan Bohm, Premedix Academy; Date: 25 March 2023; Time: 11:57 - 12:09
In this interview, Allan Böhm, MD, PhD, MBA, FESC, FJCS talks about his journey to his career as a cardiologist and scientist, and also how to improve patient care in the near future.
For Slovak-speaking audiences, you can listen to the interview
The podcast & article (in Slovak) with our Ljuba Bacharova are online!
You can learn new information about our heart, ECG, and science.
Our review Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers was published!
Podcast "ECG Diagnosis of Left Ventricular Hypertrophy" is online! Interesting interview with our Ljuba Bacharova M.D., D.Sc., M.B.A. for Mayo Clinic Cardiovascular CME
The latest issue of EMJ Cardiology is out and it features an interview with Dr. Allan Böhm where he discusses his role in the European Society of Cardiology (ESC), technological innovations in cardiovascular prevention and of course, Premedix.
Thank you to EMJ for including us and a lovely collaboration.
Read the full interview here.
Dr. Allan Böhm had a chance to talk a little bit about himself and about what we do at Premedix together with other finalists of the Exceptional young scientist in Slovakia under the age of 35 category during Juraj Petrovič's science show .jednoducho veda (.simply science) from the European Researchers' Night in collaboration with the ESET Science Award.
If you missed the opportunity to watch the episode live, you can still watch it here.
Another big success of our CEO & Chief Medical Officer, cardiologist Allan Böhm, MD, PhD, MBA, FESC, FJCS! He is the finalist of ESET Science Award - Outstanding Scientist in Slovakia Under the Age of 35.
The award is granted to a young scientist under the age of 35 whose activity may be regarded as an exceptional contribution to the Slovak scientific field with great future potential.
Allan Böhm leads the clinic and academy of precision medicine - Premedix, works at the National Institute of Cardiovascular Diseases in Bratislava, teaches at the Faculty of Medicine of the Comenius University in Bratislava and studies at the University of Oxford. In his research, he combines the methods of molecular biology, digital technologies and artificial intelligence in cardiology.
Our very own Dr. Allan Böhm, MD, PhD, MBA, FESC, FJCS was awarded! The Silver Medal of the European Society of Cardiology recognises outstanding contributions to the life and mission of the organization. He received the award during the 2022 ESC Congress in Barcelona. We are ready more than ever to deliver high-quality research and clinical care to heal patients!
The call is open! The IRIS courses are focused on developing skills to carry out research projects, based on a practical - problem-based approach, communication skills, developing skills in international research team building and networking, establishing enjoyable cross-discipline/cross-cultural collaboration, and encouraging researchers to publish scientific papers. An important effort of IRIS activities is to build an international network of young researchers and mentors in biomedical research, as well as to develop and support national research capacities and activities.
For registration click here.
Ljuba is internationally recognized scientific professional, the executive editor of the Journal of Electrocardiology, and an editorial board member of several international scientific journals. She was the president of the International Society for Electrocardiology and later also the secretary. In addition to lecturing at the Faculty of Medicine, Comenius University in Bratislava, and the Slovak Medical University, she has been organizing The IRIS Summer Schools around the globe.
Our original research article Association Between Apelin and Atrial Fibrillation in Patients With High Risk of Ischemic Stroke was selected among top 13 articles to be included in Frontiers in Cardiovascular Medicine Highlights in Cardiac Rhythmology: 2021 collection.
This collection highlights a selection of high quality articles published in 2021 from the Cardiac Rhythmology section of Frontiers in Cardiovascular Medicine.
The specialty section Cardiac Rhythmology aims to advance the understanding of underlying mechanisms, diagnosis and treatment of arrhythmias and conduction disturbances.
…what if AI could tell us which patient with acute myocardial infarction will develop cardiogenic shock…
Our abstract “Artificial intelligence model for prediction of cardiogenic shock in patients with acute coronary syndrome (STOP SHOCK)” was accepted and will be presented at this year’s ACVC congress.
Learn more about STOP SHOCK project here.
Watch our latest webinar to learn more about telemedicine and its use in current clinical practice with the speaker, Allan Böhm, MD, PhD., MBA, FESC.
Dr. Allan Böhm, PhD, MBA, FESC, lectures at the Turkish National Cardiology Congress on the Intelligent Monitoring Program, which we are currently launching at Premedix Clinic. You can read here how we can avoid acute medical emergencies thanks to artificial intelligence and telemedicine.
The new project Heart Under Control will through the use of digital medicine help people with hypertension (high blood pressure) manage their health without in-person doctor visits.
An integral part of the scientific work is being able to obtain research grants and publish results of your research. This year, Premedix Academy again decided to organize IRIS Summer School 2021 in Slovakia. The foreign faculty and participants from all around the world discussed and cooperated to create successful research study protocols.